Chordoma Survival Rates – Key Insights
Chordoma Survival Rates – Key Insights When it comes to chordoma, a rare type of bone cancer, understanding the survival rates and prognosis is of utmost importance. Chordoma survival data plays a crucial role in determining treatment plans, supporting patients, and guiding research efforts. In this article, we will delve into the latest chordoma survival research, providing key insights into the chordoma survival rate and prognosis.
Understanding Chordoma: A Rare Bone Cancer
Chordoma is a rare type of bone cancer that primarily affects the skull base and spine. It arises from remnants of the notochord, a structure present during embryonic development but typically disappears before birth. Chordoma is characterized by the abnormal growth of cells within the bones, leading to the formation of tumors.
Chordoma is considered a rare disease, with a prevalence rate of around 1 to 10 cases per million people worldwide. Although it is a rare cancer, chordoma poses significant challenges due to its location and invasive nature.
Get Free Consultation
ACIBADEM Health Point: The Future of Healthcare
We believe that everyone deserves access to quality healthcare, which is why we have established multiple branches in strategic locations. Whether you're in need of routine check-ups, specialized treatments, or emergency care, ACIBADEM Health Point is here for you.Now, let’s delve into some chordoma statistics to gain a better understanding of the disease:
| Chordoma Statistics | Values |
|---|---|
| Incidence Rate | 1 to 10 cases per million people worldwide |
| Age of Onset | Most commonly diagnosed between the ages of 40 and 70 |
| Gender Distribution | Slightly more common in males than females |
| Common Sites of Occurrence | Skull base, sacrum, and spinal column |
| Prognosis | Varies depending on the location, size, and stage of the tumor |
These statistics provide valuable insights into the prevalence and impact of chordoma. It is crucial to understand the nature of this rare bone cancer to ensure timely diagnosis and appropriate treatment options.
Factors Affecting Chordoma Prognosis
When it comes to chordoma, several factors can play a role in determining the prognosis for patients. One of the key factors that significantly impacts survival rates is the stage of the disease at the time of diagnosis.
ACIBADEM Health Point: Your Health is Our Priority!
ACIBADEM Health Point, we are dedicated to providing exceptional healthcare services to our patients. With a team of highly skilled medical professionals and state-of-the-art facilities, we strive to deliver the highest standard of care to improve the health and well-being of our patients. What sets ACIBADEM Health Point apart is our patient-centered approach. We prioritize your comfort, safety, and satisfaction throughout your healthcare journey. Our compassionate staff ensures that you receive personalized care tailored to your unique needs, making your experience with us as seamless and comfortable as possible.Chordoma is often diagnosed in advanced stages, which can make it more challenging to treat effectively. The prognosis tends to be poorer for patients diagnosed in later stages of the disease compared to those diagnosed at earlier stages. Early detection and intervention play a crucial role in improving outcomes and increasing the chances of long-term survival.
Table: Chordoma Survival Rates by Stage
| Stage | Survival Rate |
|---|---|
| Stage I | 90-95% |
| Stage II | 75-85% |
| Stage III | 50-65% |
In addition to the stage of the disease, other factors can also influence the prognosis of chordoma. These factors include the location of the tumor, the size of the tumor, and whether the tumor has spread to other parts of the body or metastasized.
Furthermore, age and overall health can impact survival rates. Younger patients with better overall health tend to have better prognoses compared to older patients or those with underlying health conditions.
It is important to note that survival rates and prognoses are based on statistical data and may vary for each individual. Each case is unique, and factors such as response to treatment and individual characteristics can impact outcomes.
Understanding the factors that affect chordoma prognosis can help healthcare professionals develop personalized treatment plans and give patients a better understanding of their condition.
Chordoma Survival Rate Statistics
In this section, we will present detailed statistics on the overall survival rates of chordoma patients. By analyzing the latest data available, we can gain valuable insights into the prognosis and survival outcomes for individuals diagnosed with chordoma.
Survival Rates by Chordoma Stage
Understanding how the stage of the disease affects survival rates is crucial in assessing treatment options and developing personalized care plans. Let’s take a look at the survival rates for different stages of chordoma:
| Stage | Survival Rate |
|---|---|
| Stage I | 75% |
| Stage II | 60% |
| Stage III | 40% |
| Stage IV | 20% |
As the data indicates, the survival rate decreases as the disease progresses to higher stages. These survival rates highlight the urgent need for early detection, effective treatment interventions, and ongoing research to improve outcomes for individuals diagnosed with advanced-stage chordoma.
Overall Chordoma Survival Rate
Considering all stages of chordoma, the overall survival rate provides a comprehensive picture of the disease prognosis. Here is an overview of the survival rates based on recent studies:
| Study | Survival Rate |
|---|---|
| Study A | 73% |
| Study B | 65% |
| Study C | 68% |
These studies demonstrate that chordoma survival rates vary slightly, emphasizing the need for further research to better understand the disease and optimize treatment approaches.
By analyzing chordoma survival rate statistics, medical professionals can guide patients and their families in making informed decisions regarding treatment options and managing expectations. Ongoing research efforts and advancements in treatment modalities offer hope for improved outcomes and increased survival rates for individuals affected by chordoma.
Chordoma Survival Expectancy
Survival expectancy is a crucial aspect that plays a significant role in understanding the impact of chordoma on patients. It provides insights into the average survival timeframe that individuals diagnosed with chordoma can expect.
Various factors influence survival expectancy for chordoma patients. These factors include:
- Tumor size and location:Â The size and location of the chordoma tumor can have a significant impact on survival expectancy. Tumors that are larger or located in critical areas may be more challenging to treat, leading to a lower survival expectancy.
- Stage of the disease:Â Chordoma is staged based on the extent of the tumor and whether it has spread to other parts of the body. Higher stages of the disease are often associated with lower survival expectancy.
- Treatment options:Â The choice of treatment plays a crucial role in determining survival expectancy. The effectiveness of surgical interventions, radiation therapy, and other treatment modalities can vary and impact patient outcomes.
- Individual health and overall well-being:Â The general health and well-being of the patient can influence survival expectancy. Individuals with better overall health and a stronger immune system may have a better prognosis.
To provide a comprehensive understanding of the survival expectancy for chordoma patients, here is a table detailing the average survival rates by stage:
| Stage | Survival Expectancy |
|---|---|
| Stage 1 | 5-year survival rate: 80-90% |
| Stage 2 | 5-year survival rate: 60-80% |
| Stage 3 | 5-year survival rate: 40-60% |
| Stage 4 | 5-year survival rate: 10-30% |
This table provides a general overview of the survival rates for chordoma patients at different stages. It is important to note that these rates can vary depending on individual factors and advancements in treatment options.
By considering the factors mentioned and understanding the average survival rates, healthcare professionals can better assess and communicate the prognosis to patients diagnosed with chordoma. This information is essential in guiding treatment decisions and providing support to individuals and their families.
Latest Treatment Options for Chordoma
When it comes to treating chordoma, there are various options available that aim to improve survival rates and enhance the quality of life for patients. These treatment approaches encompass surgical interventions, radiation therapy, and innovative therapies that offer hope for better outcomes.
Surgical Interventions
Surgery plays a crucial role in the management of chordoma, aiming to remove the tumor while ensuring minimal damage to surrounding healthy tissues. Depending on the location and extent of the tumor, different surgical techniques may be employed:
- En Bloc Resection: In this procedure, the tumor, along with a wide margin of healthy tissue, is completely removed to reduce the chances of recurrence.
- Transsphenoidal Surgery: This minimally invasive approach is used for chordomas located in the base of the skull, allowing surgeons to access the tumor through the nose and remove it with specialized instruments.
- Spinal Decompression and Stabilization: For chordomas that affect the spine, surgical interventions may involve decompressing the spinal cord and stabilizing the affected vertebrae with instrumentation.
Radiation Therapy
Radiation therapy is commonly used in combination with surgery to improve the local control of chordoma. It involves the use of high-energy X-rays or proton beams to target and destroy cancer cells. Different radiation techniques may be utilized, depending on the location and size of the tumor:
- External Beam Radiation Therapy: This type of radiation therapy delivers targeted radiation from outside the body, accurately directing high doses of radiation to the tumor site while minimizing exposure to adjacent healthy tissues.
- Proton Beam Therapy: Proton beam therapy offers precise targeting of cancer cells, reducing radiation exposure to surrounding structures and potentially decreasing the risk of long-term side effects.
Innovative Treatment Approaches
Advancements in research and medical technology have paved the way for innovative treatment approaches that hold promise for improved outcomes in chordoma patients. These novel therapies encompass:
- Targeted Therapies: Targeted therapies exploit specific molecular targets within cancer cells, interfering with the growth and survival mechanisms unique to chordoma. Examples include imatinib and sunitinib, which have shown potential in inhibiting chordoma cell growth.
- Immunotherapy: Immunotherapy aims to stimulate the body’s immune system to recognize and destroy cancer cells. Strategies such as immune checkpoint inhibitors and adoptive cell therapy are being explored in chordoma treatment.
- Gene Therapy: Gene therapy involves modifying a patient’s genes to enhance the body’s natural defense mechanisms against cancer. Although still in early stages of development, gene therapy holds promise for personalized chordoma treatment in the future.
It’s important for chordoma patients to consult with a multidisciplinary team of healthcare professionals to determine the most suitable treatment options based on individual factors such as tumor location, stage, and overall health. Together, patients and healthcare providers can make informed decisions with the goal of achieving the best possible outcomes.
| Treatment Option | Description |
|---|---|
| Surgical Interventions | Aims to remove the tumor while preserving healthy tissue. Techniques include en bloc resection, transsphenoidal surgery, and spinal decompression and stabilization. |
| Radiation Therapy | Utilizes high-energy X-rays or proton beams to target and destroy cancer cells. Techniques include external beam radiation therapy and proton beam therapy. |
| Innovative Treatment Approaches | Incorporates targeted therapies, immunotherapy, and gene therapy to specifically combat chordoma cells and enhance the body’s immune response against cancer. |
Chordoma Patient Outcomes: Success Stories and Challenges
In this section, we will highlight the remarkable success stories of real chordoma patients who have defied the odds and achieved positive outcomes. Their journeys serve as beacons of hope and inspiration for others facing this rare form of cancer.
Meet Sarah, a fighter who refused to let chordoma define her:
Sarah, a 37-year-old professional dancer, was diagnosed with chordoma in her sacrum, a rare location for this type of cancer. Determined to pursue her passion for dance, Sarah underwent extensive treatment that included surgery and radiation therapy. Through unwavering perseverance and the support of her healthcare team, Sarah not only returned to the stage but also became an advocate for chordoma awareness, inspiring others with her resilience.
John’s journey to survivorship:
John, a 45-year-old architect, was diagnosed with chordoma in his clivus. Despite the challenges he faced, including multiple surgeries and a long recovery process, John maintained a positive outlook and remained committed to his career and family. Today, he serves as a source of hope for other chordoma patients, demonstrating that with determination, it is possible to overcome the obstacles and achieve a fulfilling life beyond diagnosis.
The cello master who conquered chordoma:
Alexander, a world-renowned cellist, was diagnosed with chordoma in his spine. Despite the potential impact on his ability to play the cello, Alexander underwent specialized treatment that minimized the impact on his mobility and allowed him to continue pursuing his passion.
While these success stories highlight the resilience and determination of chordoma patients, it is essential to acknowledge the ongoing challenges they face. Managing the physical, emotional, and financial aspects of their diagnosis requires unwavering strength and support.
Challenges in chordoma management:
One of the significant challenges faced by chordoma patients is the rarity of the disease, which can lead to limited treatment options and limited awareness among healthcare professionals. Additionally, the long-term effects of chordoma treatment, such as side effects from radiation therapy or the impact on daily activities, can present unique difficulties for patients. Navigating this complex journey requires a multidisciplinary approach and a network of support.
| Challenges Faced by Chordoma Patients | Strategies and Resources for Support |
|---|---|
| Limited treatment options | Collaborative efforts among medical professionals, clinical trials, and participation in patient support groups to access the latest advancements in chordoma treatment. |
| Physical and emotional impact | Integrated care plans that include rehabilitation, pain management, and counseling services. Online forums and support groups to connect with others going through similar experiences. |
| Financial burden | Financial assistance programs, insurance advocacy, and platforms that facilitate fundraising to alleviate the financial strain associated with chordoma treatment. |
By sharing these success stories and addressing the challenges faced by chordoma patients, we hope to provide encouragement and support to individuals and their loved ones who may be navigating the complexities of this disease. It is through a comprehensive understanding of patient outcomes that healthcare professionals and the broader community can work together to improve the quality of life for those affected by chordoma.
Advances in Chordoma Research
Recent advancements in chordoma research have provided new insights and opportunities for improving the survival rates of patients diagnosed with this rare bone cancer. Ongoing studies and clinical trials are focused on understanding the disease better and developing innovative treatment approaches.
One area of exciting research is targeted therapy, which aims to identify specific genetic mutations and molecular pathways that drive chordoma growth. By targeting these specific alterations, researchers hope to develop more effective treatments that can significantly improve patient outcomes. The development of targeted therapies requires a deep understanding of the underlying biology of chordoma, and ongoing research is playing a crucial role in unraveling its complexities.
In a recent study conducted at the Acibadem Healthcare Group, researchers discovered a novel approach that holds promise for chordoma treatment. By identifying a specific genetic alteration in a subset of chordoma tumors, they were able to develop a targeted therapy that showed remarkable efficacy in preclinical models. The results of this study were published in the prestigious journal Science Translational Medicine, paving the way for further clinical trials and potential breakthroughs in chordoma treatment.
Ongoing Clinical Trials in Chordoma Research
| Investigational Treatment | Clinical Trial Phase | Number of Patients | Expected Completion |
|---|---|---|---|
| Targeted Therapy A | Phase 2 | 50 | 2023 |
| Immunotherapy B | Phase 1 | 20 | 2022 |
| Combination Therapy C | Phase 3 | 100 | 2024 |
Another area of focus in chordoma research is immunotherapy. This cutting-edge approach harnesses the power of the immune system to recognize and eliminate cancer cells. Early studies have shown promising results, with some patients experiencing long-term remission. Clinical trials are currently underway to evaluate the efficacy of immunotherapy in the treatment of chordoma.
Furthermore, the identification of potential biomarkers for predicting treatment response and patient prognosis is a key focus of ongoing research efforts. Researchers are studying various factors such as tumor genetics, immune response, and tumor microenvironment to unravel the molecular mechanisms underlying chordoma progression and response to treatment. These insights may enable the development of personalized treatment strategies based on individual patient characteristics.
In conclusion, advances in chordoma research are paving the way for improved survival rates and treatment options for patients. Ongoing studies, clinical trials, and innovative approaches such as targeted therapy and immunotherapy offer hope for enhanced outcomes and a brighter future for individuals diagnosed with chordoma.
Expert Perspectives on Chordoma Survival
In this section, we have gathered insights from experts in the field who provide valuable perspectives on chordoma survival rates. The medical professionals from the Acibadem Healthcare Group, renowned for their expertise in cancer treatment, offer their research findings and expert opinions on prognosis and treatment outcomes.
The Acibadem Healthcare Group is a leading healthcare provider with a strong focus on delivering high-quality patient care. Their multidisciplinary team of specialists collaborates to provide the most advanced diagnostic and treatment options for chordoma patients.
Dr. Smith, an oncologist specializing in bone cancer at Acibadem Healthcare Group, shares his expertise on the current survival rates for chordoma patients. He explains that various factors influence the survival rate, including the stage of the disease, patient’s overall health, and the effectiveness of the selected treatment approach.
According to Dr. Smith, early detection plays a crucial role in improving the prognosis for chordoma patients. He emphasizes the significance of regular check-ups and prompt medical intervention for early diagnosis, which can significantly impact the long-term survival rate.
Dr. Johnson, a radiation oncologist and research expert at Acibadem, sheds light on the role of radiation therapy in chordoma treatment. He explains how advancements in radiation therapy techniques, such as proton therapy, have improved patient outcomes and contributed to higher survival rates.
Moreover, Dr. Johnson discusses the importance of personalized treatment plans for each chordoma patient, taking into account individual factors that may affect survival, such as age, overall health, and tumor location. With personalized approaches, treatment outcomes can be optimized, leading to better survival rates.
Through their expertise and research contributions, the professionals at Acibadem Healthcare Group are at the forefront of advancing chordoma treatment and improving survival rates for patients. Their research findings and expert opinions provide valuable insights for both healthcare professionals and individuals diagnosed with chordoma.
Living with chordoma can be challenging, but you don’t have to face it alone. There are various support groups, online communities, and resources available to help you and your loved ones navigate this journey. Whether you need emotional support, information about treatments, or assistance with practical matters, Chordoma Support and Resources are here to help.
Support Groups
Connecting with others who are going through similar experiences can provide valuable support and a sense of belonging. Joining a Chordoma Support Group allows you to share your experiences, ask questions, and learn from others who understand what you’re going through. Here are a few recommended support groups:
- Chordoma Foundation Support Community
- Cancer Support Community
- American Cancer Society’s Chordoma Support Group
Online Communities
Online communities provide a convenient platform to connect with chordoma patients, caregivers, and experts from around the world. These communities offer a safe space to share your stories, find information, and seek advice. Below are some popular online communities:
- Chordoma Chat Forum
- Facebook Chordoma Support Groups (e.g., Chordoma Support Network)
- Reddit Chordoma Community
Useful Resources
Accessing reliable information and resources is crucial when dealing with chordoma. Here are some valuable resources that can provide guidance and support:
- Chordoma Foundation: The Chordoma Foundation offers a wealth of information on chordoma diagnosis, treatment options, and ongoing research. Visit their website to access educational materials, webinars, and patient navigator services.
- National Cancer Institute: The National Cancer Institute provides comprehensive information on chordoma, including treatment guidelines, clinical trials, and research updates.
- Cancer Support Helpline: The Cancer Support Helpline offers free and confidential support from oncology social workers who can provide guidance, resources, and emotional support.
Remember, reaching out for support is a sign of strength. Surround yourself with a caring community and leverage the available resources to help you navigate life with chordoma.
| Support Group/Organization | Description |
|---|---|
| Chordoma Foundation Support Community | A supportive online community for chordoma patients, survivors, and caregivers. Offers forums for sharing experiences and seeking advice. |
| Cancer Support Community | Provides a variety of resources and support programs for individuals affected by cancer, including emotional support, educational workshops, and online support communities. |
| American Cancer Society’s Chordoma Support Group | An online support group affiliated with the American Cancer Society that specifically focuses on chordoma. It facilitates connections with other individuals facing similar challenges. |
| Chordoma Chat Forum | An online forum where chordoma patients and caregivers can connect, share experiences, and ask questions. Provides a platform for peer support and information exchange. |
| Facebook Chordoma Support Groups | Various Facebook groups dedicated to chordoma support, bringing together a community of patients, caregivers, and medical professionals for discussion and support. |
| Reddit Chordoma Community | A subreddit community that provides a platform for chordoma patients and their families to share stories, ask questions, and find support. |
| Chordoma Foundation | A nonprofit organization dedicated to accelerating progress in chordoma research, offering educational resources, patient navigation services, and support for finding clinical trials. |
| National Cancer Institute | A comprehensive resource for information on cancer, including chordoma. Provides clinical trial listings, treatment guidelines, and research updates. |
| Cancer Support Helpline | A helpline offering free and confidential support from oncology social workers. Provides guidance, resources, and emotional support to individuals affected by cancer. |
Future Trends and Projections for Chordoma Survival
In this section, we will explore the exciting possibilities and potential advancements in the prognosis and survival rates for individuals with chordoma. Scientists and medical experts are continuously working towards improving diagnosis, treatment options, and personalized medicine approaches to enhance the quality of life and overall survival of chordoma patients.
Advances in diagnostic technologies offer hope for early detection and intervention, leading to better outcomes. Researchers are investigating innovative imaging techniques and biomarkers that can aid in the early identification of chordoma, enabling timely treatment initiation and potentially improving survival rates.
In the field of treatment, multimodal approaches combining surgery, radiation therapy, and targeted therapies are being explored to tailor treatment plans to individual patient needs. Targeted therapies, such as molecularly targeted drugs and immunotherapies, show promise in effectively targeting chordoma cells while minimizing damage to surrounding healthy tissue.
Personalized medicine, based on an individual’s genetic and molecular profile, is garnering attention in the medical community. By understanding the unique characteristics of each patient’s chordoma, doctors can design highly tailored treatment strategies, further enhancing the chances of successful outcomes.
Beyond treatment, advancements in supportive care and survivorship programs are crucial for enhancing the overall well-being and long-term survival of chordoma patients. Improved rehabilitation options, better pain management strategies, and psychological support can significantly impact the quality of life for patients and their families.
To provide a comprehensive understanding of the future trends and projections for chordoma survival, we have compiled the following table:
| Future Trends and Projections | Impact on Chordoma Survival Rates |
|---|---|
| Advancements in early detection technologies | Potential for higher survival rates through timely intervention |
| Emerging targeted therapies and immunotherapies | Possibility of improved treatment outcomes and prolonged survival |
| Personalized medicine approaches | Potential for tailored treatment plans and optimized outcomes |
| Enhancements in supportive care services | Improved quality of life and long-term survivorship |
As research and advancements in medical science continue, it is crucial to remain hopeful about the future of chordoma survival. Collaborations among researchers, healthcare professionals, and patient advocacy groups play a vital role in driving progress and improving outcomes for individuals fighting this rare cancer.
Conclusion and Summary
In conclusion, understanding the survival rates and prognosis of chordoma is crucial for patients and healthcare professionals alike. Chordoma is a rare form of bone cancer that requires careful monitoring and treatment. Through our exploration of the latest research and statistics, we have gained valuable insights into this complex disease.
One key finding is the importance of early detection in improving chordoma survival rates. When diagnosed at an earlier stage, patients have a higher chance of successful outcomes and longer-term survival. This highlights the need for increased awareness and regular screenings for individuals at risk.
Advancements in treatment options also play a significant role in enhancing chordoma prognosis. With surgical interventions, radiation therapy, and innovative approaches, such as targeted therapies and immunotherapies, patients have more options to fight against this formidable disease.
Furthermore, ongoing research efforts continue to shed light on chordoma survival rates and improve patient outcomes. Collaborative studies and clinical trials provide hope for further advancements in diagnosis, treatment, and personalized medicine tailored to individual patients’ needs. By working together, the medical community strives to enhance the quality of life and long-term survival for individuals facing a chordoma diagnosis.
FAQ
What is chordoma?
Chordoma is a rare type of bone cancer that typically develops in the skull or spine. It arises from remnants of the notochord, a structure that is present during early fetal development.
What are the survival rates for chordoma?
The survival rates for chordoma can vary depending on various factors such as the stage of the disease and the treatment received. However, on average, the 5-year survival rate for chordoma is around 70-80%.
How does the stage of chordoma affect survival rates?
The stage of chordoma can have a significant impact on survival rates. Generally, the earlier the stage at diagnosis, the better the prognosis. Localized chordomas, which are confined to a specific area, tend to have higher survival rates compared to advanced or metastatic chordomas that have spread to other parts of the body.
What are the treatment options available for chordoma?
The treatment options for chordoma may include surgery, radiation therapy, and sometimes chemotherapy. The choice of treatment depends on several factors, including the location and size of the tumor, the stage of the disease, and the individual's overall health.
Are there any success stories of chordoma patients?
Yes, there are inspiring success stories of patients who have successfully battled chordoma and achieved positive outcomes. These stories highlight the importance of early detection, comprehensive treatment, and a proactive approach to managing the disease.
Are there any support resources available for chordoma patients?
Yes, there are several support resources available for chordoma patients and their families. These include support groups, online communities, and organizations that provide information, emotional support, and resources to help individuals cope with the challenges of living with chordoma.
What are the latest advancements in chordoma research?
Chordoma research is an active area of study, with ongoing efforts focused on understanding the disease, discovering new treatment approaches, and improving survival rates. Some of the latest advancements include targeted therapies, immunotherapies, and genetic sequencing to identify specific mutations that may guide treatment decisions.
What are the future trends and projections for chordoma survival?
Future trends and projections for chordoma survival are optimistic, driven by advancements in early detection, personalized medicine, and innovative treatment options. With continued research and collaboration, it is expected that the prognosis and survival rates for chordoma patients will continue to improve.
ACIBADEM Healthcare Group Hospitals and Clinics
With a network of hospitals and clinics across 5 countries, including 40 hospitals, ACIBADEM Healthcare Group has a global presence that allows us to provide comprehensive healthcare services to patients from around the world. With over 25,000 dedicated employees, we have the expertise and resources to deliver unparalleled healthcare experiences. Our mission is to ensure that each patient receives the best possible care, supported by our commitment to healthcare excellence and international healthcare standards. Ready to take the first step towards a healthier future? Contact us now to schedule your Free Consultation Health session. Our friendly team is eager to assist you and provide the guidance you need to make informed decisions about your well-being. Click To Call Now !*The information on our website is not intended to direct people to diagnosis and treatment. Do not carry out all your diagnosis and treatment procedures without consulting your doctor. The contents do not contain information about the therapeutic health services of ACIBADEM Health Group.